来源:首都医学科学创新中心

Date: 15-17 October 2026
Location: Beijing, China
Format: In-Person Event
DNA damage repair (DDR) pathways are essential for maintaining genomic integrity in normal cells, yet in cancer these systems can become dysregulated, leading to heightened genomic instability that fuels tumour progression and therapeutic resistance. Genome Maintenance Systems in Cancer, a Nature conference, will explore how defects in DNA damage response machinery shape cancer biology and therapeutic response. Sessions will also address how genomic instability reshapes the tumour microenvironment, influences immune recognition, and affects responses to immunotherapy. By bringing together experts from academia, industry, and clinical practice, the conference aims to foster meaningful dialogue, showcase cutting-edge research, and chart a collaborative path forward for advancing our understand of genome-maintenance failures to ultimately improve patient outcomes.
Chinese Institutes for Medical Research (CIMR), Beijing
Beijing Chest Hospital, Capital Medical University (Beijing Institute of Tuberculosis and Thoracic Tumor Research)
Beijing Collaboration Medical Advance Center (CMAC)
Medlive Technology Co., Ltd.
Nature Reviews Cancer
Nature Genetics
Nature Cancer
Nature Communications
Nature Progress Oncology

Guo-Min Li
Chinese Institutes for Medical Research (CIMR)

Tao Jiang
Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Capital Medical University

Gen Lin
Beijing Chest Hospital, Capital Medical University

Zhongsheng You
Chinese Institutes for Medical Research (CIMR)

Gabrielle Brewer
Nature Reviews Cancer

Kathryn McGinnis
Nature Progress Oncology

Paraskevi Mallini
Nature Communications

Heathcliff Dorodo Garcia
Nature Cancer

Safia Danovi
Nature Genetics

Zhijian 『James』 Chen
University of Texas Southwestern Medical Center, USA

Wei Yang
National Institutes of Health (NIH), USA

Samuel Bakhoum
Geisel School of Medicine at Dartmouth, USA

Nicola Curtin
Newcastle University, UK

Liang Kang
Sun Yat-sen University, China

Tiebang Kang
Sun Yat-sen University Cancer Center, China

Li Lan
Duke University, USA

Ting Liu
Zhejiang University, China

Zhenkun Lou
Mayo Clinic, USA

Christopher Lord
The Institute of Cancer Research, UK

Xin Lu
Ludwig Institute for Cancer Research
Nuffield Department of Medicine, University of Oxford, UK

Mitsuko Masutani
Nagasaki University, Japan

René Medema
Princess Máxima Center for Pediatric Oncology, The Netherlands

Philipp Oberdoerffer
Johns Hopkins School of Medicine, USA

Elaine Sanij
St Vincent’s Institute of Medical Research, Australia

Stephen West
The Francis Crick Institute, UK

Feng Wang
Sun Yat-sen University Cancer Center, China

Zhongsheng You
Chinese Institutes for Medical Research, China

Jian Yuan
School of Medicine, Tongji University, China

Cheng-Zhong Zhang
Dana-Farber Cancer Institute and Harvard Medical School, USA

Shan Zha
Columbia University Medical Center, USA

Qing Zhong
Shanghai Jiaotong University School of Medicine, China
General Information: cimrconference@cimrbj.ac.cn
Support & Exhibition Opportunities: zhangchenhao@cimrbj.ac.cn
好文章,需要你的鼓励